3Suppliers
2Customers
2Debt Items
9Related Chains

Source-Backed Evidence Depth

Kodiak Sciences Inc. (KOD) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships
2Distinct source URLs
5High confidence
0.813Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Kodiak Sciences Inc. Suppliers

TickerNameConfidenceEvidence
LONZA LONZA 92% In August 2020, we entered into a manufacturing agreement with Lonza for the clinical and commercial supply of the Company’s antibody biopolymer conjugate drug substance
LONZA-LTD LONZA-LTD 92% In August 2020, the Company and its wholly owned subsidiary Kodiak Sciences GmbH entered into a manufacturing agreement with Lonza Ltd ("Lonza") for the clinical and commercial supply of the Company'…
FDMT 4D Molecular Therapeutics, Inc. 72% Reciprocal relationship from FDMT graph: val of a product or impose restrictions on its distribution, such as in the form of a REMS. The failure to obtain timely regulatory approval of product candid…

Kodiak Sciences Inc. Customers

TickerNameConfidenceEvidence
COMPANY-KODIAK-SCIENCES-INC COMPANY-KODIAK-SCIENCES-INC 62% es. The Company has entered into various agreements with various third parties, including clinical investigator sites, contract research organizations (“CROs”) and contract manufacturing organization…
KODIAK-SCIENCES-GMBH KODIAK-SCIENCES-GMBH 62% bstantial lead time. In the event of significant product loss and materials shortages, we may be unable to produce adequate amounts of our product candidates or products for our operational needs. Fu…

Kodiak Sciences Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
KOD-DEBT-10546 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-12-31.
KOD-DEBT Debt stack $56.0M 90% Market cache reports total debt of $56.0M.

Kodiak Sciences Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Kodiak Sciences Inc..

Kodiak Sciences Inc. Ownership

HolderNameConfidenceEvidence
KOD-OWNER-BAKER-BROS-ADVISORS-LP BAKER BROS. ADVISORS LP 90% 13F overlay lists BAKER BROS. ADVISORS LP as top holder; 192 tracked holders.

Kodiak Sciences Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
VRTX Vertex Pharmaceuticals Incorporated 100.00 2
JNJ Johnson & Johnson 100.00 2
LLY Eli Lilly and Company 100.00 2
KLRS Kalaris Therapeutics, Inc. 100.00 2
MGTX MeiraGTx Holdings plc 100.00 2
ARCT Arcturus Therapeutics Holdings Inc. 100.00 2
SNYNF Sanofi 100.00 2
RGNX REGENXBIO Inc. 50.00 2
FDMT 4D Molecular Therapeutics, Inc. 36.29 1 ['supplier']
🔐
KOD
Unlock KOD Supply Chain Data
Verified relationships include:
LONZALONZASupplier92%
LONZA-LTDLONZA-LTDSupplier92%
COMPANY-KODIAK-SCIENCES-INCCOMPANY-KODIAK-SCIENCES-INCCustomer62%
KODIAK-SCIENCES-GMBHKODIAK-SCIENCES-GMBHCustomer62%
+4 more relationships locked
Subscribe — View plans →